Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18267503 | 0.96 | PSMD14 (0.47) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL20389950 | 0.94 | PSMD14 (0.49) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL16724445 | 0.92 | KDM4E (0.47) | L3MBTL1KDM4EATMPSMD14BRCA1 | |
| SCHEMBL18267487 | 0.88 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL20382189 | 0.88 | PSMD14 (0.50) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL18267490 | 0.86 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL18267513 | 0.85 | PSMD14 (0.43) | L3MBTL1KDM4EATMPSMD14MAOA | |
| SCHEMBL20389946 | 0.84 | PSMD14 (0.43) | L3MBTL1PSMD14BRCA1MEN1KMT2A | |
| SCHEMBL17690727 | 0.84 | KDM4E (0.40) | L3MBTL1KDM4EATMPSMD14GPR3 | |
| SCHEMBL17954808 | 0.84 | PSMD14 (0.40) | L3MBTL1PSMD14MAOABRCA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9859509-B2 | Thioxanthone aromatic amine compound and organic light emitting device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2018-01-02 | — | — | US | disclosed |
| US-20160351831-A1 | THIOXANTHONE AROMATIC AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-12-01 | — | — | US | disclosed |
| US-20160351831-A1 | THIOXANTHONE AROMATIC AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160351831-A1 | THIOXANTHONE AROMATIC AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | NAT1, ACVR1, ACVRL1 | L3MBTL1 3365/4885KDM4E 2846/4885ATM 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.